D.E. Shaw & Co
DMII

D.E. Shaw & Co’s Drugs Made In America Acquisition II Corp DMII Stock Holding History

D.E. Shaw & Co’s Portfolio DMII Stock Details DMII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.9M Buy
1,390,100
+390,100
+39% +$3.89M 0.01% 1391
2025
Q4 		$9.9M Buy
+1,000,000
New +$9.89M 0.01% 1767

Other funds holding DMII

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

D.E. Shaw & Co's DMII Position: Q1 2026 in Review

D.E. Shaw & Co increased its Drugs Made In America Acquisition II Corp (DMII) stake by 39% in Q1 2026, buying an estimated $3.89M and bringing the position to 1,390,100 shares worth $13.9M. The position accounts for 0.01% of the portfolio, ranked #1391.

D.E. Shaw & Co first reported a position in DMII in Q4 2025 and has held it in 2 quarters since. 68 funds tracked by Wall St. Rank hold DMII as of Q1 2026.

  • D.E. Shaw & Co held 1,390,100 shares of Drugs Made In America Acquisition II Corp worth $13.9M as of Q1 2026.
  • D.E. Shaw & Co bought 390,100 Drugs Made In America Acquisition II Corp shares in Q1 2026, an estimated $3.89M.
  • Drugs Made In America Acquisition II Corp made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1391 holding.
  • D.E. Shaw & Co first reported a position in Drugs Made In America Acquisition II Corp in Q4 2025 and has held it in 2 quarters since.
  • 68 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.